Abstract:Objective To explore the correlation between serum amyloid A protein (SAA), serum ferritin (SF) and diabetic nephropathy (DKD) in patients with type 2 diabetes mellitus (T2DM). Methods Sixty patients with DKD between March 2017 and September 2018 were enrolled in the study group. In the same period, 60 patients with T2DM without DKD were in the control group, and 60 healthy subjects were included in the healthy group. The urinary albumin/creatinine ratio (UACR) and glomerular filtration rate (eGFR) were measured, calculated, and compared for each patient. Serum levels of SF and SAA were measured. Spearman correlation analysis was used to analyze the correlation between serum SF, SAA levels and eGFR or UACR. Logistic multiple regression analysis was used to analyze the relationship between SF, SAA levels and DKD. Results Serum SF and SAA in the study group were significantly higher than those in the control group and healthy group (P?0.05). Serum SF and SAA in the control group were significantly higher than those in the healthy group (P?0.05). Serum SF and SAA were positively correlated with UACR (rs?=?0.495 and 0.506, all P?=?0.000) and negatively correlated with eGFR (rs?=?-0.421 and -0.434, P?=?0.002 and 0.001). ROC curve analysis showed that the area under the curve of SF + SAA was 0.950 (95% CI: 0.875, 1.000), sensitivity and specificity were 82.1% and 90.1%, respectively; the area under the curve of eGFR for DKD was 0.675 (95% CI%: 0.465, 0.884), sensitivity and specificity were 72.8% and 80.2%, respectively; and that under the curve of UACR for DKD was 0.814 (95% CI%: 0.650, 0.977), sensitivity and specificity were 74.6% and 82.4%, respectively. The diagnostic value of combined detection of SF + SAA is higher than that of eGFR and UACR. Conclusion SF and SAA can reflect glomerular filtration rate to a certain extent. The combined detection of SF and SAA can be used as a method for early diagnosis of DKD.